Systematic Approaches towards the Development of Host-Directed Antiviral Therapeutics
Since the onset of antiviral therapy, viral resistance has compromised the clinical value of small-molecule drugs targeting pathogen components. As intracellular parasites, viruses complete their life cycle by hijacking a multitude of host-factors. Aiming at the latter rather than the pathogen direc...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/12/6/4027/ |
id |
doaj-d8bbe0e1e941462dbaee8a29250d1eae |
---|---|
record_format |
Article |
spelling |
doaj-d8bbe0e1e941462dbaee8a29250d1eae2020-11-24T21:54:54ZengMDPI AGInternational Journal of Molecular Sciences1422-00672011-06-011264027405210.3390/ijms12064027Systematic Approaches towards the Development of Host-Directed Antiviral TherapeuticsJames P. SnyderRichard K. PlemperPahk ThepchatriAndrew PrussiaSince the onset of antiviral therapy, viral resistance has compromised the clinical value of small-molecule drugs targeting pathogen components. As intracellular parasites, viruses complete their life cycle by hijacking a multitude of host-factors. Aiming at the latter rather than the pathogen directly, host-directed antiviral therapy has emerged as a concept to counteract evolution of viral resistance and develop broad-spectrum drug classes. This approach is propelled by bioinformatics analysis of genome-wide screens that greatly enhance insights into the complex network of host-pathogen interactions and generate a shortlist of potential gene targets from a multitude of candidates, thus setting the stage for a new era of rational identification of drug targets for host-directed antiviral therapies. With particular emphasis on human immunodeficiency virus and influenza virus, two major human pathogens, we review screens employed to elucidate host-pathogen interactions and discuss the state of database ontology approaches applicable to defining a therapeutic endpoint. The value of this strategy for drug discovery is evaluated, and perspectives for bioinformatics-driven hit identification are outlined.http://www.mdpi.com/1422-0067/12/6/4027/genome-wide screeningpathway analysisHIVInfluenza virusbioinformaticsantiviraltarget identificationRNAisiRNA |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
James P. Snyder Richard K. Plemper Pahk Thepchatri Andrew Prussia |
spellingShingle |
James P. Snyder Richard K. Plemper Pahk Thepchatri Andrew Prussia Systematic Approaches towards the Development of Host-Directed Antiviral Therapeutics International Journal of Molecular Sciences genome-wide screening pathway analysis HIV Influenza virus bioinformatics antiviral target identification RNAi siRNA |
author_facet |
James P. Snyder Richard K. Plemper Pahk Thepchatri Andrew Prussia |
author_sort |
James P. Snyder |
title |
Systematic Approaches towards the Development of Host-Directed Antiviral Therapeutics |
title_short |
Systematic Approaches towards the Development of Host-Directed Antiviral Therapeutics |
title_full |
Systematic Approaches towards the Development of Host-Directed Antiviral Therapeutics |
title_fullStr |
Systematic Approaches towards the Development of Host-Directed Antiviral Therapeutics |
title_full_unstemmed |
Systematic Approaches towards the Development of Host-Directed Antiviral Therapeutics |
title_sort |
systematic approaches towards the development of host-directed antiviral therapeutics |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2011-06-01 |
description |
Since the onset of antiviral therapy, viral resistance has compromised the clinical value of small-molecule drugs targeting pathogen components. As intracellular parasites, viruses complete their life cycle by hijacking a multitude of host-factors. Aiming at the latter rather than the pathogen directly, host-directed antiviral therapy has emerged as a concept to counteract evolution of viral resistance and develop broad-spectrum drug classes. This approach is propelled by bioinformatics analysis of genome-wide screens that greatly enhance insights into the complex network of host-pathogen interactions and generate a shortlist of potential gene targets from a multitude of candidates, thus setting the stage for a new era of rational identification of drug targets for host-directed antiviral therapies. With particular emphasis on human immunodeficiency virus and influenza virus, two major human pathogens, we review screens employed to elucidate host-pathogen interactions and discuss the state of database ontology approaches applicable to defining a therapeutic endpoint. The value of this strategy for drug discovery is evaluated, and perspectives for bioinformatics-driven hit identification are outlined. |
topic |
genome-wide screening pathway analysis HIV Influenza virus bioinformatics antiviral target identification RNAi siRNA |
url |
http://www.mdpi.com/1422-0067/12/6/4027/ |
work_keys_str_mv |
AT jamespsnyder systematicapproachestowardsthedevelopmentofhostdirectedantiviraltherapeutics AT richardkplemper systematicapproachestowardsthedevelopmentofhostdirectedantiviraltherapeutics AT pahkthepchatri systematicapproachestowardsthedevelopmentofhostdirectedantiviraltherapeutics AT andrewprussia systematicapproachestowardsthedevelopmentofhostdirectedantiviraltherapeutics |
_version_ |
1725864907489935360 |